Insights on Life Sciences
Article
Reimagining life science enterprises with agentic AI
-
Agentic AI is poised to boost the benefits from AI by changing its role from tool to coworker and catalyzing an end-to-end reimagining of the life sciences value chain.
Report
Shaping the future of India’s pharmaceutical operations
-
India, the world’s largest producer of generic medicines, faces major technological and geopolitical disruptions. Eight...
Podcast
Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future
-
Bristol Myers Squibb Chief Digital and Technology Officer Greg Meyers on how AI is helping biopharma move faster, experiment...
Article
Achieving best-in-class clinical trial delivery: The road to 2035
-
Clinical trials could take half the time and serve twice the patients, with better experience and outcomes and lower costs.
Podcast
Lykke Hinsch Gylvin on the cutting edge of clinical trial design
-
Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster....
Special collection
RewiR&D: Making more medicines that matter
A selection of recently published articles that offer practical solutions to biopharmaceutical innovation challenges. Together, these articles provide a recipe to boost R&D productivity and accelerate the development of lifesaving therapies.
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.